IFNA7 Human

IFN-alpha 7 Human Recombinant
Cat. No.
BT27340
Source
E.coli.
Synonyms

IFN alpha-7, IFN-alpha-7, IFN alpha-J, LeIF J, IFN alpha-J1, IFN-alpha-J1, IFNA7, IFNA-J, IFN-alphaJ.

Appearance
Sterile Filtered colorless solution.
Purity
Greater than 90% as determined by SDS-PAGE.
Usage
THE BioTek's products are furnished for LABORATORY RESEARCH USE ONLY. The product may not be used as drugs, agricultural or pesticidal products, food additives or household chemicals.
Shipped with Ice Packs
In Stock

Description

IFNA7 Human Recombinant produced in E.Coli is a single, non-glycosylated polypeptide chain containing 191 amino acids (24-189 a.a) and having a molecular mass of 22.3kDa.
IFNA7 is fused to a 25 amino acid His-tag at N-terminus & purified by proprietary chromatographic techniques.

Product Specs

Introduction
IFN alpha 7 (IFNA7), a member of the alpha/beta interferon family, is produced by macrophages. This interferon exhibits antiviral properties by promoting the production of two key enzymes: protein kinase and oligoadenylate synthetase.
Description
Recombinant human IFNA7, produced in E. coli, is a single, non-glycosylated polypeptide chain comprising 191 amino acids (specifically, residues 24-189). With a molecular weight of 22.3 kDa, this protein is fused to a 25 amino acid His-tag at its N-terminus and purified using proprietary chromatographic techniques.
Physical Appearance
A sterile, colorless solution that has been filtered.
Formulation
The IFNA7 protein solution (0.5 mg/ml) is supplied in a buffer containing 20 mM Tris-HCl (pH 8.0), 0.4 M urea, and 10% glycerol.
Stability
For short-term storage (2-4 weeks), the product can be stored at 4°C. For extended periods, store frozen at -20°C. The addition of a carrier protein (0.1% HSA or BSA) is recommended for long-term storage. Avoid repeated freeze-thaw cycles.
Purity
Purity exceeds 90% as determined by SDS-PAGE analysis.
Synonyms

IFN alpha-7, IFN-alpha-7, IFN alpha-J, LeIF J, IFN alpha-J1, IFN-alpha-J1, IFNA7, IFNA-J, IFN-alphaJ.

Source
E.coli.
Amino Acid Sequence
MGSSHHHHHH SSGLVPRGSH MGSHMCDLPQ THSLRNRRAL ILLAQMGRIS PFSCLKDRHE FRFPEEEFDG HQFQKTQAIS VLHEMIQQTF NLFSTEDSSA AWEQSLLEKF STELYQQLND LEACVIQEVG VEETPLMNED FILAVRKYFQ RITLYLMEKK YSPCAWEVVR AEIMRSFSFS TNLKKGLRRK D.

Product Science Overview

Structure and Production

IFN-α7 is one of the 13 subtypes of interferon-alpha, which are produced mainly by leukocytes . The recombinant form of IFN-α7 is produced using mammalian cell expression systems, such as Chinese hamster ovary (CHO) cells . This method ensures that the recombinant protein is similar to the naturally occurring human protein in terms of structure and function.

The molecular mass of recombinant human IFN-α7 is approximately 22 kDa . It is typically formulated in a phosphate buffer solution containing human serum albumin (HSA) and saccharose to maintain stability and solubility .

Biological Activity

IFN-α7 exerts its effects by binding to a specific cell surface receptor complex known as IFNAR, which consists of two subunits: IFNAR1 and IFNAR2 . Upon binding to this receptor, a signaling cascade is initiated, involving the Janus kinase (JAK) and signal transducer and activator of transcription (STAT) pathways . This leads to the formation of the ISGF3 transcriptional complex, which binds to interferon-stimulated response elements (ISRE) in the promoters of numerous interferon-stimulated genes (ISGs) .

The activation of these genes results in a wide range of biological activities, including:

  • Antiviral effects: IFN-α7 inhibits viral replication and enhances the immune response against viral infections .
  • Antiproliferative effects: It can inhibit the growth of certain types of cancer cells .
  • Immunomodulatory effects: IFN-α7 modulates the activity of various immune cells, enhancing the overall immune response .
Clinical Applications

Recombinant human IFN-α7 is primarily used in research settings to study its biological activities and potential therapeutic applications . It has shown promise in the treatment of viral infections, certain types of cancer, and immune-related disorders . However, its clinical use is limited by its short half-life, which necessitates frequent dosing .

Storage and Stability

Recombinant human IFN-α7 is typically shipped at room temperature and should be stored at -20°C upon receipt . The lyophilized product is stable for up to six months at -20°C. Once reconstituted, it should be aliquoted and stored at -80°C to avoid repeated freeze-thaw cycles .

Quick Inquiry

Personal Email Detected
Please use an institutional or corporate email address for inquiries. Personal email accounts ( such as Gmail, Yahoo, and Outlook) are not accepted. *
© Copyright 2024 Thebiotek. All Rights Reserved.